Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 509-513, March 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shellabarger, C. J.
Right arrow Articles by Cronkite, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shellabarger, C. J.
Right arrow Articles by Cronkite, E. P.

Results of Fractionation and Protraction of Total-Body Radiation on Rat Mammary Neoplasia

Claire J. Shellabarger1, Victor P. Bond, Gonzalo E. Aponte2 and Eugene P. Cronkite

Brookhaven National Laboratory, Upton, New York3

Female Sprague-Dawley rats showed a high incidence of mammary neoplasia and a large number of mammary neoplasms following exposure to a single dose of 500 r of 60Co gamma, total-body radiation. When studied over the entire life-span, these responses were not different when the 500 r were given at either 40 or 160 days of age. Fractionation and protraction of this dose into 4 x 125 r spread over 2 weeks or 8 x 62.5 r spread over 4 weeks or 16 x 31.25 r spread over 8 weeks or 32 x 15.625 r spread over 16 weeks did not change the incidence of rats with mammary neoplasia or the total number of mammary neoplasms compared to a single dose of 500 r. However, a decreased yield of adenofibroma-fibroadenomas and an increased yield of adenocarcinomas were observed. Mammary adenocarcinomas occur very late in the life of nonexposed females long after a significant incidence of adenofibroma-fibroadenomas has been established and then only in a ratio of approximately 1:5. All radiation exposures tended to shift the appearance of the adenocarcinomas forward in time so that they appeared before the adenofibroma-fibroadenomas with the resulting ratio of approximately 1–4 adenocarcinomas to 1 adenofibroma-fibroadenoma.

1 Present address: Zoology Department and Medical School, University of Michigan, Ann Arbor, Mich. Supported in part by USPHS Grant NIH CA-05496.

2 Present address: Pathology Department, The Jefferson Medical School, Philadelphia, Pa.

3 Brookhaven National Laboratory supported by the USAEC.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.